Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
New companies 22 · Follow-on 0
Stages: Series A 7, Series C+ 7, Series B 5, Undisclosed 2, Growth 1
Estuary Biotherapeutics $93M Series ACircle Pharma, Inc. $92.5M Series ESolstice Oncology $225M Series ANew companies 15 · Follow-on 0
Stages: Series C+ 5, Series A 4, Series B 4, Undisclosed 2
Star Therapeutics $200M Private financingOMass Therapeutics $310M Series CSoufflé Therapeutics $135M Series BNew companies 15 · Follow-on 0
Stages: Series B 6, Series C+ 4, Seed 2, Series A 2, Undisclosed 1
BigHat Biosciences $75M Series CCircle Pharma, Inc. $92.5M Series EMoonwalk Biosciences $70M Series BNew companies 14 · Follow-on 0
Stages: Series B 7, Undisclosed 3, Series A 2, Series C+ 2
Soufflé Therapeutics $135M Series BEncoded Therapeutics Inc. $275M Series FMoonwalk Biosciences $70M Series BNew companies 11 · Follow-on 0
Stages: Series A 4, Series B 3, Series C+ 3, Undisclosed 1
Star Therapeutics $200M Private financingLeal Therapeutics $30M Series AAccro Bioscience $50M Series CNew companies 11 · Follow-on 0
Stages: Series A 3, Series B 3, Undisclosed 3, Series C+ 2
BigHat Biosciences $75M Series CLeal Therapeutics $30M Series AKhartis Therapeutics $50M Series BNew companies 10 · Follow-on 0
Stages: Series C+ 4, Series B 3, Series A 2, Undisclosed 1
Estuary Biotherapeutics $93M Series AOMass Therapeutics $310M Series CEncoded Therapeutics Inc. $275M Series FNew companies 10 · Follow-on 0
Stages: Seed 6, Series A 2, Series B 1, Series C+ 1
Molagri Undisclosed SeedSensible Biotechnologies $47M Series AWonderTx $125K SeedNew companies 8 · Follow-on 0
Stages: Series A 3, Seed 2, Series C+ 2, Undisclosed 1
Nouscom €120M Series DEdonia €15M Series A financing package including non-dilutive and bank fundingOne Biosciences €3.3M i-Démo 5 grant (France 2030)New companies 8 · Follow-on 0
Stages: Series A 4, Series C+ 3, Series B 1
OMass Therapeutics $310M Series CSling Therapeutics, Inc. $123M Series CSolstice Oncology $225M Series ANew companies 8 · Follow-on 0
Stages: Series C+ 4, Series A 2, Series B 2
OMass Therapeutics $310M Series CAbcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 8 · Follow-on 0
Stages: Series C+ 6, Series B 2
BigHat Biosciences $75M Series CBasecamp Research $140M Series CEnveda $311M Series ENew companies 8 · Follow-on 0
Stages: Seed 2, Series B 2, Undisclosed 2, Series A 1, Series C+ 1
EnginZyme SEK 75M Equity roundMironid $46M Series BBionyra Pharma $165M Series ANew companies 8 · Follow-on 0
Stages: Seed 6, Pre-seed 1, Series A 1
Fermeate $2M SeedTippingPoint Biosciences $4.5M SeedCauldron Ferm $13.3M Series A2New companies 7 · Follow-on 0
Stages: Seed 3, Series A 2, Series C+ 2
OMass Therapeutics $310M Series CReEmerge, Inc. $37M Series AVivid Dx $15M SeedNew companies 7 · Follow-on 0
Stages: Series C+ 4, Series B 3
Soufflé Therapeutics $135M Series BEpicrispr Biotechnologies $90M Series CAdvanCell $315M Series DNew companies 7 · Follow-on 0
Stages: Series B 4, Series C+ 2, Undisclosed 1
Soufflé Therapeutics $135M Series BEncoded Therapeutics Inc. $275M Series FLifeMine Therapeutics $263M Series D+Series ENew companies 7 · Follow-on 0
Stages: Seed 3, Series A 3, Series B 1
RegCell, Inc. $44M Series AEvvy $40M Series BCentury Health $5M SeedNew companies 7 · Follow-on 0
Stages: Seed 4, Pre-seed 1, Series B 1, Undisclosed 1
Revier Therapeutics €6M SeedComputomics €6.3M Series BNanoStruct €2.6M SeedNew companies 6 · Follow-on 0
Stages: Series A 3, Seed 2, Series C+ 1
Warp Sciences $215M Series AWarhound $200M SeedEnveda $311M Series ENew companies 6 · Follow-on 0
Stages: Series B 4, Series A 1, Series C+ 1
Nouscom €120M Series DVaderis Therapeutics $152M Series BRQ Bio $115M Series ANew companies 6 · Follow-on 0
Stages: Series A 3, Seed 1, Series C+ 1, Undisclosed 1
Nouscom €120M Series DTwoStep Therapeutics $62.5M Series ARemepy $36M Series ANew companies 6 · Follow-on 0
Stages: Series C+ 3, Series B 2, Series A 1
Microbiotica £36M Series C first closeOMass Therapeutics $310M Series CDraig Therapeutics $65M Series BNew companies 6 · Follow-on 0
Stages: Series B 3, Series C+ 2, Series A 1
Estuary Biotherapeutics $93M Series ASuperluminal Medicines $60M Series BDraig Therapeutics $65M Series BNew companies 5 · Follow-on 1
Stages: Series C+ 3, Series B 2, Series A 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 5 · Follow-on 1
Stages: Series B 3, Series A 2, Series C+ 1
Soufflé Therapeutics $135M Series BInduPro $77M Series BSonoThera $125M Series BNew companies 6 · Follow-on 0
Stages: Seed 2, Series C+ 2, Series A 1, Series B 1
Evvy $40M Series BTransfyr $25M SeedChai Discovery $400M Series CNew companies 6 · Follow-on 0
Stages: Seed 2, Series A 2, Series B 1, Undisclosed 1
TwoStep Therapeutics $62.5M Series ATRIMTECH Therapeutics $47M Seed+Crossbow Therapeutics $77M Series BNew companies 6 · Follow-on 0
Stages: Series C+ 2, Seed 1, Series A 1, Series B 1, Undisclosed 1
Moonwalk Biosciences $70M Series BPramaana Labs $27M SeedNovellia $18M Series ANew companies 5 · Follow-on 1
Stages: Series A 2, Series C+ 2, Series B 1, Undisclosed 1
AusperBio $120M Series CVivacta Biotechnology $50M Series A+Vivatides Therapeutics $54M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.